VI003 - Pre school boosters given before 5 years of age

VI003 - Pre school boosters given before 5 years of age

The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF).                                                                     

Indicator definition

Indicator ID

Description

VI003

The percentage of children who reached 5 years old in the preceding 12 months, who have received a reinforcing dose of DTaP/IPV and at least 2 doses of MMR between the ages of 1 and 5 years.

What do the business rules mean?

What makes a patient eligible?

Patients are eligible for the VI003 denominator if they turned 5 years old during the contract year.

How to achieve the indicator

To meet the criteria for VI003, eligible patients must have had two doses of MMR from age 1 to less than 5 years old and a booster dose of DTaP/IPV before the age of 5 years old

What will remove patients from eligibility?

  1. Both MMR and DTaP/IPV are contraindicated before the patient’s 5th birthday. 

  2. Patient received 2 doses of MMR but the DTaP/IPV vaccine is contraindicated before the patient’s 5th birthday.

  3. Patient received a reinforcing dose of DTaP/IPV, but the MMR vaccine is contraindicated before the patient’s 5th birthday.

  4. Patient was newly registered after 59 months of age (4y11m) with a history of 2 MMR doses but no DTaP/IPV prior to registering.

  5. Patient was newly registered after 59 months of age (4y11m) with a history of 1 MMR dose as well as a DTaP/IPV booster prior to registering.

  6. Patient was newly registered after 58 months of age (4y10m) with a history of 1 MMR dose but no DTaP/IPV prior to registering.

  7. Patient was newly registered after 58 months of age (4y10m) with no record of an MMR dose but they had received a DTaP/IPV booster prior to registering.

  8. Patient was newly registered after 57 months of age (4y9m) with no record of MMR or DTaP/IPV prior to registering.

There are no Personalised Care Adjustments to remove a patient if vaccination has been declined. This is likely to make the indicator hard to achieve, either due to a small number of dissenting patients or due to transient populations where new patients completed a different vaccination schedule abroad.

If a patient achieves the indicator at any point during the year, any exclusions that have also been added are ignored.

Hints and tips for achieving this indicator

The PCIT searches can help you to identify patients that you need to action to achieve this indicator.  

SNOMED codes used in this indicator

The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD).  Not all of these may be present or selectable in all clinical systems.

Codes for MMR vaccination contraindication (MMRCON_COD)

SNOMED code

SNOMED code description

219096004

Adverse reaction to component of vaccine product containing Measles morbillivirus antigen

275974002Measles/mumps/rubella vaccine contraindicated
293114004Adverse reaction to component of vaccine product containing Mumps orthorubulavirus antigen
293119009Adverse reaction to component of vaccine product containing Rubella virus antigen
293125008Adverse reaction to component of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens
294650000Allergy to component of vaccine product containing Mumps orthorubulavirus antigen
294656006Allergy to component of vaccine product containing Rubella virus antigen
294662001Allergy to component of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens
719467000Measles vaccination contraindicated
719473004Rubella vaccination contraindicated

Codes for Diphtheria, tetanus, pertussis, polio containing vaccine contraindications (DTAPIPVCON_COD)

SNOMED code

SNOMED code description

1083421000000107

Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination contraindicated

171284002Pertussis vaccine contraindicated
219084006Adverse reaction to component of vaccine product containing Clostridium tetani antigen
219085007Adverse reaction to component of vaccine product containing Corynebacterium diphtheriae antigen
293108006Adverse reaction to component of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens
293109003Adverse reaction to component of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens
293115003Adverse reaction to component of vaccine product containing Bordetella pertussis antigen
293117006Adverse reaction to component of vaccine product containing Human poliovirus antigen
294642009Allergy to component of vaccine product containing Corynebacterium diphtheriae antigen
294644005Allergy to component of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens
294645006
Allergy to component of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens
294651001
Allergy to component of vaccine product containing Bordetella pertussis antigen
294654009
Allergy to component of vaccine product containing Human poliovirus antigen
294658007
Allergy to component of vaccine product containing Clostridium tetani antigen
715163003
Diphtheria vaccination contraindicated
719474005
Tetanus vaccination contraindicated
719476007
Poliomyelitis vaccination contraindicated
897351000000102
Diphtheria, tetanus, acellular pertussis, inactivated polio vaccination contraindicated
898291000000101
Diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b vaccination contraindicated
903241000000108
Diphtheria, tetanus, inactivated polio vaccination contraindicated


    • Related Articles

    • IIF VI-01 / VI-02 / VI-03

      VI-01 (NCD002) Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March This indicator is looking at patients born before 1st April 1958. There are some exclusions for patients with ...

    • SMOK004 - Smokers given advice

      The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description SMOK004 The percentage of patients aged 15 or over who are recorded as ...

    • VI002 - 1st MMR given before 18 months of age

      The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description VI002 The percentage of children who reached 18 months old in the preceding ...

    • BP002 - BP recorded in last 5 years

      The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description BP002 The percentage of patients aged 45 or over who have a record of blood ...

    • CS005 - Age 25-49 with up to date smear

      The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description CS005 The percentage of women eligible for screening and aged 25-49 years ...